{"id":6630,"date":"2025-07-02T14:10:58","date_gmt":"2025-07-02T12:10:58","guid":{"rendered":"https:\/\/bsicos.i3a.es\/?p=6630"},"modified":"2025-07-03T10:31:46","modified_gmt":"2025-07-03T08:31:46","slug":"non-invasive-risk-assessment-in-atrial-fibrillation","status":"publish","type":"post","link":"https:\/\/bsicos.i3a.es\/es\/non-invasive-risk-assessment-in-atrial-fibrillation\/","title":{"rendered":"NON-INVASIVE RISK ASSESSMENT IN ATRIAL FIBRILLATION"},"content":{"rendered":"
\t\t\t\t
\n\t\t\t\t\t\t\t
  • \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t

    L\u00edneas de investigaci\u00f3n<\/a><\/h3>\n

    NON-INVASIVE RISK ASSESSMENT IN ATRIAL FIBRILLATION<\/h1>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/li>\n\t\t<\/ul>\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t
    1. <\/a><\/li>\n\t\t\t\t\t\t\t\t\t<\/ol>\n\n\t\t\t\t
      \n\t\t\t\t\t\n\t\t\t\t\t\t<\/em>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\n\t\t\t\t
      \n\t\t\t\t\t\n\t\t\t\t\t\t<\/em>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n\n
      \n\t\t\t\t\t\t\t

      \n\t\t\t\t\t\tResearch line\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t

      \n\t\t\t\t\t\t
      <\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n<\/div><\/div><\/div><\/div><\/div>
      \n
      \n\t
      \n
      \n
      \n

      Nonivasive atrial fibrillation diagnosis, characterization, prediction, and risk stratification from the ECG, including:<\/p>\n

        \n
      1. Development of ECG-based automatic AF detection.<\/li>\n
      2. Development of signal processing and mathematical modelling techniques for the characterization of AF episode patterns in paroxysmal AF.<\/li>\n
      3. Identification of ECG-based biomarkers for AF \/ stroke risk stratification.<\/li>\n
      4. Identification of ECG-based markers associated with the presence of other atrial cardiomyopathies including fibrosis and atrial hypertrophy.<\/li>\n
      5. ECG-based ventricular vulnerability risk markers measurable during AF rhythm<\/li>\n<\/ol>\n

         <\/p>\n

        with the ultimate goal of improving risk assessment as well as better understanding arrhythmia progression.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div><\/div>

        \n
        \n\t\t\"ECG-AF\"\n\t<\/div>\n\n<\/div><\/div><\/div><\/div><\/div>\n\n
        <\/div>
        <\/div>
        <\/div>
        <\/div>
        <\/div>
        <\/div>
        <\/div>
        <\/div><\/div><\/div>

        Investigator in charge<\/span><\/h2><\/div><\/div><\/div>
        \"Alba<\/a><\/div>

        Alba Mart\u00edn Yebra<\/a><\/h3><\/div><\/div><\/div><\/div>
        \"Juan<\/a><\/div>

        Juan Pablo Mart\u00ednez Cort\u00e9s<\/a><\/h3><\/div><\/div><\/div><\/div><\/div><\/div>
        <\/div><\/div>\n\n
        \n\t\t\t\t\t\t\t

        \n\t\t\t\t\t\tTechnologies and targeting sectors\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t

        \n\t\t\t\t\t\t
        <\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>
        \n
        \n\t